Quick Overview: At the International Workshop on Non-Hodgkin Lymphoma ( John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, ... The Conservative Corner Title: “The more things

Iwnhl 2015 Roundtable The Changing - Detailed Overview & Context

At the International Workshop on Non-Hodgkin Lymphoma ( John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, ... The Conservative Corner Title: “The more things Catherine Bollard, MBChB, MD, FRACP, FRCPA from the Children's National Health System and the George Washington ... John Gribben, MD, DSc, FRCPath, FMed Sci of Barts Cancer Institute, London, UK discusses the highlights from the first day of the ... Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Prof Randy Gascoyne (British Columbia Cancer ...

Assessment and Diagnosis: Roundtable Discussion Brookings India hosted a Development Seminar on “World Class – A Story of Adversity, Transformation, and Success at NYU ...

Photo Gallery

iwNHL 2015 roundtable: The changing treatment landscape for non-Hodgkin lymphoma
iwNHL 2015 roundtable: Future directions for the management of non-Hodgkin lymphoma
iwNHL 2015 roundtable: Day 2 highlights – ibrutinib for diffuse large B-cell lymphoma
iwNHL 2015 roundtable: Improving treatment strategies for T-cell lymphoma
iwNHL 2015 roundtable: Immune checkpoint blockade for non-Hodgkin lymphoma
iwNHL 2015 roundtable: Molecular biology of T-cell lymphoma
iwNHL 2015 roundtable: Day 1 highlights
iwNHL 2015 roundtable: Day 2 highlights – PI3K inhibitors
iwNHL 2015 roundtable: Day 2 highlights – CAR T-cell therapy for non-Hodgkin lymphoma
🏴‍☠️ The Conservative Corner: “The more things change, the more they stay the same”
How immunotherapies are re-shaping the treatment of lymphoma
Determining effective combinations of immune checkpoint inhibitors for lymphoma
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored